Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models.
about
Is tau ready for admission to the prion club?Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing ProblemRoles of tau protein in health and disease.The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease NeuropathologyDissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegenerationRelationship between tau pathology and neuroinflammation in Alzheimer's disease.Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation.Apoptosis and in vitro Alzheimer disease neuronal models.Tau protein modifications and interactions: their role in function and dysfunction.Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF.Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis.Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease.Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model.NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease.Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.Amyloidogenesis of Tau protein.Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.Mapping interactions with the chaperone network reveals factors that protect against tau aggregation
P2860
Q24630925-DBDEFC26-D53C-44BC-BD88-7C28C132B4AEQ27004724-9249B579-CC34-45E5-B50E-09C4DB3ADF8BQ33559303-7B4C6F54-D435-4687-8202-1D74ABE23A59Q33839157-89F9C842-E4B9-4420-9C27-A355A05A75BAQ33982246-B1A0B05B-0DBE-4DA2-A961-08E97723621BQ33995490-61BBF468-C912-4C4D-A768-74D12B18D597Q34110227-6BB29779-A642-4742-8CB7-860550543555Q37235009-DEE0A679-A316-49B1-84AD-39ABD87E79E2Q37513632-79033C89-A9C0-4F30-BF9C-5D369D76D11DQ37684106-8C3C311A-8E66-4D75-A17E-5A081ACD01D4Q37731918-235F145E-E253-44E8-B38D-C350EB2AF375Q38039856-21A170B6-B2BB-414C-B6AD-FC12CF7B2279Q38319146-3481A06C-69C0-453B-A78B-B9A3210A112BQ38872162-8B130188-3E21-473C-AF42-ABE0C84909FCQ40796484-BC2F5FDE-F867-49D5-ACD2-5CA3C23E6286Q41427586-B86CFFF2-ABF1-4C81-975B-CFA60F296A57Q42873156-912FCC6F-2313-456D-BDD6-7D395E259B39Q47715943-94339258-9DD4-433B-ABF8-1FECFB00CFF4Q48532697-E7505176-C021-40A6-8E5F-2DF30AD77480Q52598834-5BD77FCB-34D1-4F1A-9E8B-13C2A3149C6FQ57560752-137E9FB8-8765-4A2A-B165-1A964B81C9CC
P2860
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Identification of a caspase-de ...... al Alzheimer's disease models.
@en
Identification of a caspase-de ...... al Alzheimer's disease models.
@nl
type
label
Identification of a caspase-de ...... al Alzheimer's disease models.
@en
Identification of a caspase-de ...... al Alzheimer's disease models.
@nl
prefLabel
Identification of a caspase-de ...... al Alzheimer's disease models.
@en
Identification of a caspase-de ...... al Alzheimer's disease models.
@nl
P2093
P50
P1476
Identification of a caspase-de ...... mal Alzheimer's disease models
@en
P2093
P304
P356
10.1016/J.MCN.2008.03.011
P577
2008-04-10T00:00:00Z